| # | Drug | Count |
|---|---|---|
| 0 | OCTREOTIDE ACETATE | 52 |
| 1 | RANITIDINE | 41 |
| 2 | ETOPOSIDE | 37 |
| 3 | CARBOPLATIN | 32 |
| 4 | ADALIMUMAB | 31 |
| 5 | ASPIRIN | 25 |
| 6 | ASPIRIN 325 MG | 25 |
| 7 | ASPIRIN 81 MG | 25 |
| 8 | INFLIXIMAB | 24 |
| 9 | PREDNISONE | 24 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ACETAMINOPHEN, CAFFEINE, PYRILAMINE MALEATE | 4 | 0.0267 |
| 1 | LUTETIUM LU 177 DOTATATE | 10 | 0.0017 |
| 2 | OCTREOTIDE ACETATE | 52 | 0.0017 |
| 3 | ARTIFICIAL TEARS | 4 | 0.0015 |
| 4 | POLYVINYL ALCOHOL, POVIDONE | 4 | 0.0015 |
| 5 | SILODOSIN | 4 | 0.0010 |
| 6 | BREXUCABTAGENE AUTOLEUCEL | 2 | 0.0009 |
| 7 | INFLIXIMAB-DYYB | 3 | 0.0009 |
| 8 | ISAVUCONAZONIUM SULFATE | 3 | 0.0008 |
| 9 | BICALUTAMIDE | 11 | 0.0007 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 72 |
| 1 | Nonsteroidal Anti-inflammatory Drug [EPC] | 53 |
| 2 | Platinum-based Drug [EPC] | 48 |
| 3 | Tumor Necrosis Factor Blocker [EPC] | 47 |
| 4 | Kinase Inhibitor [EPC] | 43 |
| 5 | Topoisomerase Inhibitor [EPC] | 39 |
| 6 | Proton Pump Inhibitor [EPC] | 31 |
| 7 | Alkylating Drug [EPC] | 27 |
| 8 | Platelet Aggregation Inhibitor [EPC] | 25 |
| 9 | Calcium Channel Blocker [EPC] | 23 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 7 | 0.0102 |
| 1 | Somatostatin Analog [EPC] | 12 | 0.0017 |
| 2 | Plasma Volume Expander [EPC] | 4 | 0.0013 |
| 3 | CD38-directed Cytolytic Antibody [EPC] | 5 | 0.0009 |
| 4 | Topoisomerase Inhibitor [EPC] | 39 | 0.0005 |
| 5 | Provitamin D2 Compound [EPC] | 15 | 0.0005 |
| 6 | beta Lactamase Inhibitor [EPC] | 2 | 0.0004 |
| 7 | CCR5 Co-receptor Antagonist [EPC] | 1 | 0.0004 |
| 8 | Substance P/Neurokinin-1 Receptor Antagonist [EPC] | 3 | 0.0003 |
| 9 | Programmed Death Ligand-1 Blocker [EPC] | 7 | 0.0003 |